Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly-Mee Yu

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
BMJ Open|February 12, 2014
Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysisGunnstein Norheim, Manish Sadarangani, Omar Omar, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up studyAmeneh Khatami, Matthew D Snape, Jacek Wysocki, et al.
BMJ Open|March 7, 2020
Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)Simon D Kyle, Claire Madigan, Nargis Begum, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 25, 2015
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 monthsFiona McQuaid, Matthew D Snape, Tessa M John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunizationMatthew D Snape, Dominic F Kelly, Penny Salt, et al.
Immunology|January 30, 2009
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccineDominic F Kelly, Matthew D Snape, Kirsten P Perrett, et al.
Journal of Medical Internet Research|December 11, 2019
Effectiveness and Cost-Effectiveness of a Self-Guided Internet Intervention for Social Anxiety Symptoms in a General Population Sample: Randomized Controlled TrialJohn Powell, Veronika Williams, Helen Atherton, et al.
Digital Health|June 27, 2018
Effectiveness and cost-effectiveness of a fully self-guided internet-based intervention for sub-clinical social anxiety symptoms: Protocol for a randomised controlled trialJohn Powell, Helen Atherton, Veronika Williams, et al.
Journal of Medical Internet Research|May 5, 2017
Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled TrialAndrew Farmer, Veronika Williams, Carmelo Velardo, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
BMJ Open|February 12, 2014
Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysisGunnstein Norheim, Manish Sadarangani, Omar Omar, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up studyAmeneh Khatami, Matthew D Snape, Jacek Wysocki, et al.
BMJ Open|March 7, 2020
Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)Simon D Kyle, Claire Madigan, Nargis Begum, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 25, 2015
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 monthsFiona McQuaid, Matthew D Snape, Tessa M John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunizationMatthew D Snape, Dominic F Kelly, Penny Salt, et al.
Immunology|January 30, 2009
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccineDominic F Kelly, Matthew D Snape, Kirsten P Perrett, et al.
Journal of Medical Internet Research|December 11, 2019
Effectiveness and Cost-Effectiveness of a Self-Guided Internet Intervention for Social Anxiety Symptoms in a General Population Sample: Randomized Controlled TrialJohn Powell, Veronika Williams, Helen Atherton, et al.
Digital Health|June 27, 2018
Effectiveness and cost-effectiveness of a fully self-guided internet-based intervention for sub-clinical social anxiety symptoms: Protocol for a randomised controlled trialJohn Powell, Helen Atherton, Veronika Williams, et al.
Journal of Medical Internet Research|May 5, 2017
Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled TrialAndrew Farmer, Veronika Williams, Carmelo Velardo, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
Pageof 19